Rheal A. Towner

Dr. Rheal A. Towner

Advanced Magnetic Resonance Center, Oklahoma Medical Research Foundation, Oklahoma City, 73104 OK, USA

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 July 2010 in Journal of Magnetic Resonance Imaging
Verified
Journal Article
Open access
PDF file
SDSabrina Doblas
Sabrina Doblas
THTing He
Ting He
DSDebbie Saunders
Debbie Saunders
JPJamie Pearson
Jamie Pearson
JHJessica Hoyle
Jessica Hoyle
RTRheal A. Towner
Rheal A. Towner
Purpose: To evaluate the added value of non–contrast‐enhanced MR angiography (MRA) to conventional MR imaging for a detailed characterization of different rodent glioma models.Materials and Methods: Intracerebral tumor cell implantation and chemical induction methods were implemented to obtain rat C6, 9L/LacZ, F98, RG2, and ethyl‐nitrosourea (ENU) ‐induced glioma models, a human U87 MG tumor model as well as a mouse GL261 glioma model. MR assessments were regularly conducted on a 7 Tesla Bruker BioSpin system. The tumor border sharpness and growth characteristics of each glioma model were assessed from T2‐weighted images. Neovascularization and vascular alterations inherent to each model were characterized by assessing absolute blood volumes, vessel density, length, and diameter using Mathematica and Amira software.Results: The 9L/LacZ and ENU gliomas both presented flaws that hinder their use as reliable brain tumor models. C6 gliomas were slightly invasive and induced moderate vascular alterations, whereas GL261 tumors dramatically altered the brain vessels in the glioma region. F98, RG2, and U87 are infiltrative models that produced dramatic vascular alterations.Conclusion: MRI and MRA provided crucial in vivo information to identify a distinctive “fingerprint” for each of our seven rodent glioma models. J. Magn. Reson. Imaging 2010;32:267–275.

1 January 2013 in Neurosurgery
Verified
Journal Article
Closed access
PDF file
RTRheal A. Towner
Rheal A. Towner
RJRandy L. Jensen
Randy L. Jensen
HCHoward Colman
Howard Colman
BVBrian Vaillant
Brian Vaillant
NSNataliya Smith
Nataliya Smith
JWJonathan D. Wren
Jonathan D. Wren
BACKGROUND:. Glioblastoma multiforme (GBM), a high-grade glioma, is characterized by being diffuse, invasive, and highly angiogenic and has a very poor

23 September 2011 in NMR in Biomedicine
Verified
Journal Article
Closed access
PDF file
SDSabrina Doblas
Sabrina Doblas
THTing He
Ting He
DSDebra Saunders
Debra Saunders
JHJessica Hoyle
Jessica Hoyle
NSNataliya Smith
Nataliya Smith
RTRheal A. Towner
Rheal A. Towner

1 February 2019 in Translational Oncology
Verified
Journal Article
Open access
RTRheal A. Towner
Rheal A. Towner
NSNataliya Smith
Nataliya Smith
DSDebra Saunders
Debra Saunders
CBChase A. Brown
Chase A. Brown
XCXue Cai
Xue Cai
JBJames Battiste
James Battiste
Treatment of glioblastoma (GBM) remains a challenge using conventional chemotherapy, such as temozolomide (TMZ), and is often ineffective as a result of drug resistance. We have assessed a novel nitrone-based agent, OKN-007, and found it to be effective in decreasing tumor volumes and increasing survival in orthotopic GBM xenografts by decreasing cell proliferation and angiogenesis and increasing apoptosis. In this study, we assessed combining OKN-007 with TMZ in vivo in a human G55 GBM orthotopic xenograft model and in vitro in TMZ-resistant and TMZ-sensitive human GBM cell lines. For the in vivo studies, magnetic resonance imaging was used to assess tumor growth and vascular alterations. Percent animal survival was also determined. For the in vitro studies, cell growth, IC50 values, RNA-seq, RT-PCR, and ELISA were used to assess growth inhibition, possible mechanism-of actions (MOAs) associated with combined OKN-007 + TMZ versus TMZ alone, and gene and protein expression levels, respectively. Microarray analysis of OKN-007-treated rat F98 glioma tumors was also carried out to determine possible MOAs of OKN-007 in glioma-bearing animals either treated or not treated with OKN-007. OKN-007 seems to elicit its effect on GBM tumors via inhibition of tumorigenic TGF-β1, which affects the extracellular matrix. When combined with TMZ, OKN-007 significantly increases percent survival, decreases tumor volumes, and normalizes tumor blood vasculature in vivo compared to untreated tumors and seems to affect TMZ-resistant GBM cells possibly via IDO-1, SUMO2, and PFN1 in vitro. Combined OKN-007 + TMZ may be a potentially potent treatment strategy for GBM patients.

7 February 2018 in GeroScience
Verified
Journal Article
Closed access
PDF file
RTRheal A. Towner
Rheal A. Towner
DSD. Saunders
D. Saunders
NSN. Smith
N. Smith
WTW. Towler
W. Towler
MCM. Cruz
M. Cruz
KMK. A. Morton
K. A. Morton

22 May 2019 in Bioengineering
Verified
Journal Article
Open access
PDF file
Chung-Hao LeeChung-Hao Lee
Chung-Hao Lee
DLDevin Laurence
Devin Laurence
CRColton Ross
Colton Ross
KKKatherine E. Kramer
Katherine E. Kramer
AAnju R. Babu
Anju R. Babu
YWYi Wu
Yi Wu
Proper tricuspid valve (TV) function is essential to unidirectional blood flow through the right side of the heart. Alterations to the tricuspid valvular components, such as the TV annulus, may lead to functional tricuspid regurgitation (FTR), where the valve is unable to prevent undesired backflow of blood from the right ventricle into the right atrium during systole. Various treatment options are currently available for FTR; however, research for the tricuspid heart valve, functional tricuspid regurgitation, and the relevant treatment methodologies are limited due to the pervasive expectation among cardiac surgeons and cardiologists that FTR will naturally regress after repair of left-sided heart valve lesions. Recent studies have focused on (i) understanding the function of the TV and the initiation or progression of FTR using both in-vivo and in-vitro methods, (ii) quantifying the biomechanical properties of the tricuspid valve apparatus as well as its surrounding heart tissue, and (iii) performing computational modeling of the TV to provide new insight into its biomechanical and physiological function. This review paper focuses on these advances and summarizes recent research relevant to the TV within the scope of FTR. Moreover, this review also provides future perspectives and extensions critical to enhancing the current understanding of the functioning and remodeling tricuspid valve in both the healthy and pathophysiological states.